Authors
Isabel M Ott, Madison S Strine, Anne E Watkins, Maikel Boot, Chaney C Kalinich, Christina A Harden, Chantal BF Vogels, Arnau Casanovas-Massana, Adam J Moore, M Catherine Muenker, Maura Nakahata, Maria Tokuyama, Allison Nelson, John Fournier, Santos Bermejo, Melissa Campbell, Rupak Datta, Charles S Dela Cruz, Shelli F Farhadian, Albert I Ko, Akiko Iwasaki, Nathan D Grubaugh, Craig B Wilen, Anne L Wyllie
Publication date
2021/4
Journal
Emerging infectious diseases
Volume
27
Issue
4
Pages
1146
Publisher
Centers for Disease Control and Prevention
Description
The expense of saliva collection devices designed to stabilize severe acute respiratory syndrome coronavirus 2 RNA is prohibitive to mass testing. However, virus RNA in nonsupplemented saliva is stable for extended periods and at elevated temperatures. Simple plastic tubes for saliva collection will make large-scale testing and continued surveillance easier.
Scholar articles
IM Ott, MS Strine, AE Watkins, M Boot, CC Kalinich… - MedRxiv, 2020
IM Ott, MS Strine, AE Watkins, M Boot, CC Kalinich… - Emerging infectious diseases, 2021